Skip to content

H.R. 3520 · 119th Congress (2025–2027)

STAND Against Emerging Opioids Act

To amend the Controlled Substances Act to provide for the scheduling of tianeptine as a schedule III substance, and for other purposes.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 3520’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Jimmy Panetta (D-CA-19)
Cosponsors
2 cosponsors

1 original · 1 later

  1. Rep. August Pfluger (R-TX-11)· Original · May 20, 2025
  2. Rep. David Kustoff (R-TN-8)· Later · Jun 12, 2025
Policy area
Crime and Law Enforcement

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred May 20, 2025
  2. HouseJudiciaryReferred May 20, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. STAND Against Emerging Opioids Act

    Display title, Short title · Introduced in House

  2. Scheduling Tianeptine and Analogues Now to Defend Against Emerging Opioids Act

    Short title · Introduced in House

  3. To amend the Controlled Substances Act to provide for the scheduling of tianeptine as a schedule III substance, and for other purposes.

    Official title · Introduced in House